In the latest trading session, 241.75 million HCW Biologics Inc (NASDAQ:HCWB) shares changed hands as the company’s beta touched 0.81. With the company’s most recent per share price at $0.64 changing hands around $0.36 or 128.25% at last look, the market valuation stands at $24.01M. HCWB’s current price is a discount, trading about -293.75% off its 52-week high of $2.52. The share price had its 52-week low at $0.21, which suggests the last value was 67.19% up since then. When we look at HCW Biologics Inc’s average trading volume, we note the 10-day average is 0.32 million shares, with the 3-month average coming to 9.77 million.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Instantly HCWB is in green as seen in intraday trades today. With action 92.42%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 42.34%, with the 5-day performance at 92.42% in the green. However, in the 30-day time frame, HCW Biologics Inc (NASDAQ:HCWB) is 42.34% up. Looking at the short shares, we see there were 8092.0 shares sold at short interest cover period of 0.28 days.
HCW Biologics Inc (HCWB) estimates and forecasts
Year-over-year growth is forecast to reach 222.75% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 7M. The company’s revenue for the corresponding quarters a year ago was 1.32M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 428.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -34.57%. The 2025 estimates are for HCW Biologics Inc earnings to increase by 18.57%, but the outlook for the next 5-year period is at 8.29% per year.
HCWB Dividends
HCW Biologics Inc is expected to release its next quarterly earnings report in March.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 52.30% of HCW Biologics Inc shares while 3.13% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.56%. There are 3.13% institutions holding the HCW Biologics Inc stock share, with AVANTAX PLANNING PARTNERS, INC. the top institutional holder. As of 2024-06-30, the company held 0.751% of the shares, roughly 0.28 million HCWB shares worth $0.18 million.
HIGHTOWER ADVISORS, LLC holds the second largest percentage of outstanding shares, with 0.4857% or 0.18 million shares worth $0.12 million as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund. With 94.58 shares estimated at $62491.0 under it, the former controlled 0.25% of total outstanding shares. On the other hand, Bridgeway Funds Inc-Ultra Small Company Market Fund held about 0.22% of the shares, roughly 84.7 shares worth around $55961.0.
